Retina II: AMD – Don’t Let That Retina Degenerate!
Theme:
Retina
When:
1:30 PM, Friday 16 Jun 2023
(1 hour 30 minutes)
Where:
Québec City Convention Centre
- Room 307 AB | Salle 307 AB
How:
Learning Objectives:
At the end of this session, participants will be able to:
- Assess new therapeutic modalities for dry age-related macular degeneration
- Assess current therapies for wet age-related macular degeneration
- Assess complications of anti-VGF treatments and preventative measures
CanMEDS Roles: Medical Expert, Scholar
Sub Sessions
- Minimizing Pain With Intravitreal Injections
- Québec City Convention Centre - Room 307 AB | Salle 307 AB
- 13 minutes | 1:30 PM - 1:43 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Keynote Speaker | Invité.e d'honneur
- Q&A
- 3 minutes | 1:43 PM - 1:46 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Efficacy of intravitreal pegcetacoplan in geographic atrophy: 24-month results from the Phase 3 OAKS and DERBY trials
- Presenter Dr. Raman Tuli
- 7 minutes | 1:46 PM - 1:53 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Paper Presentation | Présentation d'article
- Q&A
- 3 minutes | 1:53 PM - 1:56 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- The Incidence of post intravitreal injection endophthalmitis with and without anterior chamber paracentesis
- Presenter Dr. Dara Onasanya
- 7 minutes | 1:56 PM - 2:03 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Paper Presentation | Présentation d'article
- Q&A
- 3 minutes | 2:03 PM - 2:06 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Current Management of Wet Macular Degeneration
- Québec City Convention Centre - Room 307 AB | Salle 307 AB
- 13 minutes | 2:06 PM - 2:19 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Keynote Speaker | Invité.e d'honneur
- Q&A
- 3 minutes | 2:19 PM - 2:22 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Machine Learning Quantification of Fluid Volume in Eyes with Retinal Vein Occlusion Undergoing Treatment with Aflibercept: The REVOLT study
- Presenter Dr. Austin Pereira (University of Toronto)
- 7 minutes | 2:22 PM - 2:29 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Paper Presentation | Présentation d'article
- Q&A
- 3 minutes | 2:29 PM - 2:32 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Bevacizumab versus Ranibizumab in Treating Retinopathy of Prematurity
- Presenter Tianwei (Ellen) Zhou (University of Toronto)
- 7 minutes | 2:32 PM - 2:39 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Paper Presentation | Présentation d'article
- Q&A
- 3 minutes | 2:39 PM - 2:42 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Comparison of endophthalmitis rates following alcohol-based chlorhexidine and povidone-iodine antisepsis for intravitreal anti VEGF injections
- Presenter Dr. Amit Mishra MD
- 7 minutes | 2:42 PM - 2:49 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!
- Paper Presentation | Présentation d'article
- Q&A
- 3 minutes | 2:49 PM - 2:52 PM Part of: Retina II: AMD – Don’t Let That Retina Degenerate!